Moneycontrol PRO
HomeNewsIndiaCOVID-19 vaccine tracker: Over 17 lakh doses administered in India on August 1

COVID-19 vaccine tracker: Over 17 lakh doses administered in India on August 1

On the 198th day of the vaccination drive on August 1, 17,06,598 received jabs, taking the total coverage to 47,22,23,639.

August 02, 2021 / 11:19 IST

More than 17.06 lakh vaccine doses were administered in India on August 1, the Union Health Ministry's data said. With that, the cumulative number of COVID-19 vaccine doses administered in the country crossed 47.22 crore.

On the 198th day of the vaccination drive on August 1, 17,06,598 received jabs, taking the total coverage to 47,22,23,639.

Follow our LIVE blog for the latest updates on coronavirus pandemic

Here are key developments related to the COVID-19 vaccination process:

- The Delhi health department, on August 1, issued fresh orders asking district authorities to restrict 20 percent doses of Covishield and 40 percent doses of Covaxin for the first shot. The remaining doses will be reserved for the second shot till the supply situation improves, an official said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

- Britain will offer COVID-19 booster vaccines to 32 million Britons starting early next month with up to 2,000 pharmacies set to deliver the programme. The campaign could start as soon as September 6, which would see the rollout completed by early December if it goes to plan

- From shopping vouchers and pizza discounts to Uber reminders, the UK is planning a so-called vouchers for vaccines scheme to encourage greater uptake of COVID-19 vaccines among the younger age groups of the country.
A number of ride-hailing and food delivery apps will be offering discounted travel and meals to people who get vaccinated, with offers including free lifts to vaccine centres and cheap meals for those already inoculated. Uber, Bolt, Deliveroo and Pizza Pilgrims are among the brands in the UK that are part of the government-backed scheme.

- The July 31 deadline to complete administering the first COVID-19 vaccine dose to all eligible beneficiaries in Goa has been missed as only 87 percent of the target has been met, a senior official told PTI. The July 31 deadline was set by Chief Minister Pramod Sawant with the aim of getting the state prepared to tackle a possible third wave of the infection.

- The AYUSH Ministry has collaborated with UK's London School of Hygiene and Tropical Medicine (LSHTM) to conduct a study on Ashwagandha for promoting recovery from COVID-19. The All India Institute of Ayurveda (AIIA), an autonomous body under the Ministry of AYUSH, and LSHTM recently signed a memorandum of understanding to conduct clinical trials of Ashwagandha on 2,000 people in three UK cities -- Leicester, Birmingham and London (Southall and Wembley), the ministry said in a statement.

Here are the vaccination counts for some states:

StatesTotal Beneficiaries
Andhra Pradesh2,18,87,925
Arunachal Pradesh 8,47,524
Assam1,08,27,165
Bihar2,47,02,048
Chandigarh8,44,439
Chhattisgarh1,20,10,136
Delhi1,01,06,714
Goa 13,35,328
Gujarat 3,37,40,643
Haryana1,19,45,898
Himachal Pradesh52,42,253
Jharkhand97,19,028
Karnataka3,06,65,708
Kerala2,03,70,704
Madhya Pradesh3,22,28,891
Maharashtra 4,46,72,654
Odisha1,66,37,788
Punjab98,25,946
Rajasthan3,28,15,090
Tamil Nadu 2,33,07,320
Telangana1,48,43,306
Uttar Pradesh4,84,43,142
Uttarakhand 60,02,934
West Bengal2,98,07,373
(With inputs from PTI)

Click here for Moneycontrol’s full coverage of the coronavirus pandemic

Moneycontrol News
first published: Aug 2, 2021 11:19 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347